文献速递主动脉疾病

临床经验增加与实践方案改变改善复杂主动脉瘤开窗分支血管腔内修复预后

Increasing clinical experience and changes in practice protocols improved outcomes of fenestrated branched endovascular repair of complex aortic aneurysms.
PubMed 文献 · J Vasc Surg · 2025-05-21

该研究回顾847例复杂腹主动脉瘤和胸腹主动脉瘤患者,由同一术者在两个中心行开窗分支血管腔内修复(2007-2024年)。随着临床经验积累和实践方案改变,尽管动脉瘤复杂性和患者复杂性显著增加,早期主要不良事件仍显著减少,总体30天死亡率为1.7%。

要点

  • 经验积累至第4四分位时预后显著改善,学习曲线需32例连续病例,100例达平台期。
  • 融合/锥形束CT与总手术时间和辐射暴露显著减少相关(P < .001)。
  • 治疗性而非预防性CSFD及经股总动脉入路对I-III型TAAA预后无不良影响,并改善范围较小动脉瘤患者预后。

核心结论

  • 在大样本累积经验中,开窗分支血管腔内修复术死亡率低(1.7%)。
  • 临床经验增加和实践方案改变与开窗分支血管腔内修复预后显著改善相关,尽管解剖和患者复杂性显著增加。

研究设计与样本

  • 回顾性分析847例连续患者(男性72%;中位年龄74岁,四分位距69-79岁),由同一术者在两个中心治疗(2007-2024年)。
  • 其中590例患者在前瞻性研究器械豁免研究下治疗。
  • 研究期间分为四个四分位:Q1(2007-2014)、Q2(2014-2017)、Q3(2017-2020)、Q4(2020-2024)。

主要发现

  • 从Q1到Q4,I-III型TAAA比例从16%增至58%(P < .001),慢性夹层后动脉瘤从1.9%增至21%(P < .001),症状性动脉瘤从5.2%增至10%(P < .001),遗传性胸主动脉疾病从0.5%增至4.2%(P = .011),既往EVAR从8.5%增至51%(P < .001)。
  • 尽管动脉瘤复杂性增加,MAE随时间及四分位显著减少(P < .01)。
  • 融合/锥形束CT使用与总手术时间和辐射暴露显著减少相关(P < .001)。
  • 总体30天死亡率为1.7%(14/847)。
  • CAAA和IV型TAAA的MAE发生率显著降低(P < .01),I-III型TAAA在采用治疗性CSFD和经股总动脉入路后保持稳定。

关键数值与推荐

  • CAAA患者中,21.2%采用治疗性而非预防性CSFD,10.7%采用经股总动脉入路。
  • IV型动脉瘤患者中,47.3%采用治疗性CSFD,22.5%采用经股总动脉入路。

临床怎么用

  • 实践方案改变包括2012年常规使用融合/锥形束CT,2019年第三季度采用治疗性而非预防性CSFD,2020年第四季度优先使用经股总动脉入路。
  • 作者结论认为,治疗性而非预防性CSFD及经股总动脉入路对I-III型TAAA预后无不良影响,并改善范围较小动脉瘤患者预后。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the impact of increased clinical experience and changes in practice protocols on the incidence of early major adverse events (MAEs) during fenestrated-branched endovascular aortic repair (FB-EVAR) of complex abdominal aortic aneurysms (CAAAs) and thoracoabdominal aortic aneurysms (TAAAs). METHODS: Clinical outcomes of 847 consecutive patients (72% males; median age, 74 years; interquartile range, 69-79 years) treated by the same operator in two centers were reviewed (2007-2024). Of these, 590 patients were treated under a prospective investigational device exemption study. Changes in practice protocols included routine use of fusion/cone beam computed tomography (2012), therapeutic instead of prophylactic cerebrospinal fluid drainage (CSFD) (2019, Q3) and preferential use of total transfemoral access (2020, Q4). The primary end point was 30-day/in-hospital MAE assessment using learning curve cumulative sum analysis per quartiles of experience. The study period was divided into four quartiles: Q1 (2007-2014), Q2 (2014-2017), Q3 (2017-2020), and Q4 (2020-2024). RESULTS: There was a significant increase in the proportion of extent I to III TAAA (from 16% to 58%; P < .001), chronic postdissection aneurysms (from 1.9% to 21%; P < .001), symptomatic aneurysms (from 5.2% to 10%; P < .001), heritable thoracic aortic diseases (from 0.5% to 4.2%; P = .011), and prior EVAR (from 8.5% to 51%; P < .001) between Q1 and Q4 experience. Despite the increased aneurysm complexity, MAEs significantly decreased over time and across quartiles (P < .01). The use of fusion/cone beam computed tomography was associated with a significant decrease in total operative time and radiation exposure (P < .001). Overall 30-day mortality was 1.7% (14/847). The incidence of MAEs significantly decreased for CAAAs and extent IV TAAAs (P < .01) and remained stable for extent I to III TAAAs after institution of therapeutic instead of prophylactic CSFD and total transfemoral access. Learning curve cumulative sum analysis indicates that 32 consecutive cases were needed to reach a learning curve and 100 cases to reach plateau, with significantly improved outcomes in the fourth quartile of experience. CONCLUSIONS: FB-EVAR was performed with low mortality (1.7%) in a large cumulative experience. Increased clinical experience and changes in practice protocol associated with significantly improved outcomes of FB-EVAR, despite a significant increase in anatomical and patient complexity. The institution of therapeutic instead of prophylactic CSFD and total transfemoral access had no deleterious effect on outcomes of extent I to III TAAAs but improved outcomes in patients with less extensive aneurysms. Among CAAA patients, 21.2% had therapeutic instead of prophylactic CSFD, and 10.7% had total transfemoral access. For extent IV aneurysms, 47.3% had therapeutic CSFD, and 22.5% had total transfemoral access.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Babocs D, Kanamori LR, Schmid BP, et al. Increasing clinical experience and changes in practice protocols improved outcomes of fenestrated branched endovascular repair of complex aortic aneurysms. J Vasc Surg. 2025. PMID: 40409435. doi:10.1016/j.jvs.2025.05.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。